Chemotherapy for Participants With Lymphoma

Clinical trial NCT00436280 · COMPLETED

Trial details

NCT number: NCT00436280
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Large Cell, Diffuse

Start date: 2007-02-01
Primary completion: 2009-11-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.